This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Haoling Gao: Innovator in Pharmaceutical Ingredients
Introduction
Haoling Gao is a distinguished inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of active pharmaceutical ingredients. His innovative work has led to the creation of a unique compound that addresses specific impurities in pharmaceutical formulations.
Latest Patents
Haoling Gao holds a patent for a "nemonoxacin malate active pharmaceutical ingredient with low combination impurities, and a preparation method thereof." This patent outlines a method for preparing the nemonoxacin malate active pharmaceutical ingredient, which includes steps such as providing a C1-C3 alcohol/water mixed solvent and performing cooling crystallization. This innovative approach ensures the production of high-quality pharmaceutical ingredients.
Career Highlights
Gao is currently associated with Zhejiang Medicine Co., Ltd., specifically at the Xinchang Pharmaceutical Factory. His role in this organization has allowed him to focus on research and development, contributing to advancements in pharmaceutical manufacturing processes. His expertise in the field has been recognized through his patent and ongoing research efforts.
Collaborations
Haoling Gao has collaborated with notable colleagues, including Gang Fan and Dadong Shen. These partnerships have fostered a collaborative environment that enhances innovation and drives the development of new pharmaceutical solutions.
Conclusion
Haoling Gao's contributions to the pharmaceutical industry exemplify the importance of innovation in developing effective medical treatments. His work not only addresses critical challenges in pharmaceutical formulations but also sets a precedent for future research in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile